Robb S. Friedman Named Medical Director of the New Beth Israel Deaconess Cancer Center in Needham

Date: August 22, 2013

Needham, MA – Beth Israel Deaconess Hospital is pleased to announce the appointment of Robb S. Friedman, MD, to medical director of the new Beth Israel Deaconess Cancer Center at BID-Needham. Dr. Friedman joins BID-Needham and Beth Israel Deaconess Medical Center (BIDMC) from Harvard Vanguard Medical Associates where he held the position of associate chief of the Department of Hematology/Oncology.

"We are very excited to have Robb on our medical staff," said BID-Needham President and CEO John M. Fogarty. “Dr. Friedman is superbly qualified for this role given his background in clinical leadership in both academic and community-based cancer programs."

The new cancer center, scheduled to open in late summer 2014, is part of the Beth Israel Deaconess Cancer Center and Surgical Pavilion now under construction in Needham. The project was created through the unique collaboration of BID-Needham and BIDMC. The 30,000 square foot, three-story building will significantly improve and expand cancer and surgical services available to the community.

"The Beth Israel Deaconess Cancer Center will deliver cutting-edge multidisciplinary cancer care in the community setting,” said Dr. Friedman. “I truly believe that cancer care needs to be accessible, and for many patients, we will be able to provide excellent care without a commute into Boston. I am thrilled to be chosen as medical director, it is a remarkable opportunity for me to develop the cancer program at Needham. I have found the staff at BID-Needham and BIDMC incredibly welcoming and collegial. I look forward to meeting the entire BID-Needham medical staff and learning about what our community would like to see at the new BID Cancer Center."

Prior to the cancer center opening, Dr. Friedman will be treating patients at BID-Needham and at BIDMC. He will be seeing hematology and oncology patients in Needham on Mondays, Wednesdays, Thursdays and Fridays. He will be at BIDMC on Tuesdays.

“Robb Friedman exemplifies our vision of a leader,” remarked Lowell Schnipper, MD, clinical director of the BIDMC Cancer Center. “I know he will work with our physicians, nurses and staff from BIDMC to create an extraordinary team in Needham with the mission of providing academic medical center level care with the added benefits of convenience and highly personalized attention.”

Dr. Friedman received his medical degree and completed his internal medicine residency at Georgetown University School of Medicine. He went on to complete his fellowship in Hematology/Oncology at Tufts Medical Center.

Dr. Friedman is married to Elisa Friedman, an editor at Harvard Business Publishing. They have two sons.

About Beth Israel Deaconess Cancer Center and Surgical Pavilion
The new Beth Israel Deaconess Cancer Center and Surgical Pavilion, now under construction at BID-Needham, is a collaborative project with BID-Needham and BIDMC. This new center, scheduled to open in late summer 2014, will bring comprehensive cancer care and more advanced surgery to many communities outside of Boston. The 30,000 square foot, three-story building will be home to Beth Israel Deaconess Medical Center’s world renowned cancer care, giving patients in the western suburbs even greater access to a full array of services including advanced imaging systems; six new infusion bays; and a radiation oncology suite with a state-of-the-art linear accelerator to facilitate delivery of advanced conformal radiation therapy. Patients will also have access to the same leading-edge clinical trials and novel treatments available at BIDMC. Radiation oncology services previously provided at BIDMC’s facility in Waltham will move to Needham. The new surgical pavilion is located on the second floor of the center and will feature two new operating rooms with the equipment that can accommodate more advanced surgeries including cancer, colorectal, orthopaedic, urology, otolaryngology and general surgery. The expansion will also include a large post anesthesia care unit (PACU). Both the cancer center and the surgical pavilion have been designed with significant input from patients and clinicians who have worked alongside the architects to create the ideal patient-centered experience.

About Beth Israel Deaconess Hospital-Needham

Beth Israel Deaconess Hospital-Needham (BID-Needham) is a licensed 58-bed acute care community hospital affiliated with Beth Israel Deaconess Medical Center (BIDMC) in Boston. BID-Needham has served residents in Needham, Newton, Dedham, Dover, Medfield, Wellesley, Westwood and other surrounding communities for more than 100 years. In 2002, Beth Israel Deaconess Medical Center and Deaconess-Glover Hospital formalized their long-standing, collaborative relationship with a direct affiliation. The two hospitals’ emergency departments have been clinically integrated since 2000. The direct affiliation has facilitated the integration of staff and resources in other clinical areas such as hospital medicine (hospitalists), orthopaedics, cardiology, radiology, general surgery, oncology and pathology. For more information please go to www.bidneedham.org or like us on Facebook and follow us on Twitter